Short communicationRosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats
Introduction
Obesity and related cardiometabolic syndromes are becoming the major health concern across the globe. Indeed, with population aging, the prevalence of glucose intolerance and non-insulin dependent diabetes mellitus is on the rise and consumption of high fat diet is a known risk factor for these physiological changes. Insulin resistance, which is usually associated with hypertrophic obesity, is believed to be the major underlying mechanism for these abnormalities (Nisoli and Carruba, 2004). In addition to this, insulin resistance is under scrutiny for its effect on cognitive function in recent years (Elias et al., 2003). Patients with Alzheimer's disease, a most common form of dementia have shown elevated plasma insulin levels and reduced insulin sensitivity (Watson and Craft, 2004). Conversely, abnormalities in insulin metabolism may influence the onset of Alzheimer's disease via their role in synthesis and degradation of β-amyloid, a peptide held central to Alzheimer's neuropathology. Additionally, recent studies have indicated that certain signal transduction pathways [e.g., glycogen synthase kinase (GSK)-3] downstream of the insulin receptor, may also promote the generation of Aβ peptides by modulating the cleavage of the parent APP at the γ-secretase site, a site determinant of Aβ amyloidogenicity (Ho et al., 2004).
Type 2 diabetic rats such as the Goto–Kakizaki showed impaired memory on lever-press task, a behavioral paradigm that allows response-reinforcement learning (Moreira et al., 2007). Similarly, the obese Zucker rat, a widely used model of type 2 diabetes showed impaired performance on a variable-interval delayed alternation test of learning and memory (Winocur et al., 2005). Further, Streptozotocin-diabetic rats also showed deficits in spatial learning on a water maze task (Biessels et al., 1998). These evidences suggest that hyperinsulinemia and type 2 diabetes, a condition associated with insulin resistance, increase the risk of memory impairment and Alzheimer's disease (Luchsinger et al., 2004, Watson and Craft, 2003).
Consistent with this notion, rats fed with higher amount of dietary fat showed widespread cognitive deficit on various tasks of learning and memory such as, Olton's radial arm maze, a non-spatial test of conditional associative learning, the Hebb–Williams complex maze series, and a variable-interval delayed alternation test that highlighted deficits in rule-learning and specific memory function (Greenwood and Young, 2001, Molteni et al., 2002, Winocur and Greenwood, 1999). The mechanisms of adverse effects of dietary fat on cognitive function are not completely understood. However, it is well established that high fat diet leads to glucose intolerance and insulin resistance in rats (Srinivasan et al., 2004), raising the possibility that abnormalities in glucose utilization might contribute to memory deficits. Neurotransmitter metabolism, cerebral blood flow, blood brain barrier and microvascular function may all be affected to varying degrees by chronic disruption of glucose metabolism (McCall, 2004). This contention is strengthened by the observation that acute intraperitoneal administration of glucose (100 mg/kg) improves the high fat diet induced cognitive deficits in rat (Greenwood and Winocur, 2001).
If the disruption of glucose metabolism is contributing to the hippocampal function impairment, a reasonable hypothesis is that insulin sensitizer's should restore the hippocampal function and a corresponding cognition in high fat diet fed rats. The anti-diabetic compounds such as rosiglitazone and pioglitazone are considered as an insulin sensitizer's and mediate their effect through activation of the peroxisome proliferator-activated receptor-gamma (PPAR-γ) (Vasudevan and Balasubramanyam, 2004). Activation of PPAR-responsive genes accounts for the maintains of an appropriate level of expression of key gluco- and liporegulatory molecules, as well as other proteins that are involved in the transduction of the insulin signal (Stumvoll, 2003). The present study was therefore designed to study the effect of rosiglitazone treatment on high fat diet induced spatial memory impairment in rat. Rosiglitazone was used in present study as it does not cross the intact blood brain barrier in rodents (Pedersen et al., 2006). Thus, the effects of rosiglitazone on the cognitive function may be indirectly mediated through its peripheral actions. To begin to test this hypothesis, we subjected high fat diet fed rats to the rosiglitazone treatment and determined if the peripheral insulin sensitization action of the drug is concomitant with improved learning and memory performance in rat.
Section snippets
Materials
Glucose (GOD-POD), triglycerides (GPO-POD) and total cholesterol (CHOD-POD) kits were purchased from Accurex (Mumbai, India). Enzyme linked immuno sorbate assay (ELISA) kit for rat insulin was obtained from Linco Research Inc, USA. Other chemicals used were of analytical reagent grade. Casein, Cholesterol and dl-Methionine were procured from HiMedia, (Mumbai, India). Heparin was purchased from s.d. fine chemicals (India) and rosiglitazone was kindly gifted by Sun Pharma Ltd, India.
Animals
Adult male SD
Effect of PPAR-γ agonist on biochemical parameters of high fat diet fed rats
High fat diet fed rats comparatively gained approximately 10% more weight than normal pellet diet fed rats over 5-week study period. A small (+ 28%) but statistically significant (P < 0.001) increase in plasma glucose was observed in high fat diet fed rats. In addition, there was a significant (P < 0.001) increase in plasma triglyceride (+ 114%), cholesterol (+ 100%), and basal insulin (+ 149%) levels in high fat diet fed rats. Treatment of rosiglitazone for 7 days showed trend towards less body weight
Discussion
Currently there is a growing interest in clarifying the roles of insulin resistance, hyperinsulinemia and non-insulin dependent diabetes mellitus in the pathogenesis of Alzheimer's disease and associated memory impairment. It is difficult however, to separate the “direct” effect of alterations in insulin homeostasis on the brain from the consequences of the accompanying alteration in peripheral and/or central glucose homeostasis, which themselves can affect the brain. It has been previously
References (26)
- et al.
Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface
Eur. J. Pharmacol.
(2004) - et al.
Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment
Brain Res.
(1998) - et al.
Learning and memory impairment in rats fed a high saturated fat diet
Behav. Neural. Biol.
(1990) - et al.
Glucose treatment reduces memory deficits in young adult rats fed high-fat diets
Neurobiol. Learn. Mem.
(2001) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
Eur. J. Pharmacol.
(2004)Cerebral glucose metabolism in diabetes mellitus
Eur. J. Pharmacol.
(2004)- et al.
A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning
Neuroscience
(2002) - et al.
Diabetic type II Goto–Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task
Behav. Brain Res.
(2007) - et al.
Emerging aspects of pharmacotherapy for obesity and metabolic syndrome
Pharmacol. Res.
(2004) - et al.
Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats
Life Sci.
(2006)
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Exp. Neurol.
Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease
Eur. J. Pharmacol.
The effects of high fat diets and environmental influences on cognitive performance in rats
Behav. Brain. Res.
Cited by (85)
A systematic review of preclinical studies exploring the role of insulin signalling in executive function and memory
2023, Neuroscience and Biobehavioral ReviewsBrain insulin signaling as a potential mediator of early life adversity effects on physical and mental health
2023, Neuroscience and Biobehavioral ReviewsHigh fat diet and its effects on cognitive health: alterations of neuronal and vascular components of brain
2021, Physiology and BehaviorBrain insulin action: Implications for the treatment of schizophrenia
2020, NeuropharmacologyAssociation of dietary n-3 polyunsaturated fatty acids intake with depressive symptoms in midlife women
2020, Journal of Affective Disorders